Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany

Heidenreich A, Fuchshofen R, Elsner S, Gieseler F, Katalinic A, Hübner J (2023)
Journal of Cancer Research and Clinical Oncology 149(19): 17297-17306.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 518.74 KB
Autor*in
Heidenreich, AndreasUniBi; Fuchshofen, Rabea; Elsner, Susanne; Gieseler, Frank; Katalinic, Alexander; Hübner, Joachim
Abstract / Bemerkung
**Abstract**

**Purpose**
Elderly cancer patients are less likely to be treated in accordance with evidence-based guideline recommendations. This study examines patient-related factors associated with deviations from guideline recommendations.

**Methods**
Using medical documentation and cancer registry data, we investigated the treatment courses of female breast cancer patients aged 50 and older in Germany regarding compliance with German guidelines. Participants completed a questionnaire querying factors hypothesized to be associated with guideline adherence. We conducted univariate analyses to explore the data and select variables for multivariate logistic regression to estimate adjusted odds ratios.

**Results**
Of 1150 participants, 206 (17.9%) were treated in deviation from guideline recommendations. Patients 70 years and older were more likely to be treated deviating from guideline recommendations than patients 50–69 years old (OR: 2.07; 95% CI: 1.52–2.80). Patients aged 50–69 years who reported that quality of life guided their treatment decision were more likely to be treated in deviation from guideline recommendations (AOR: 2.08; 95% CI: 1.11–3.92) than the elderly. In older patients, higher age was associated with an increased chance of receiving guideline-discordant care (AOR: 1.06; 95% CI: 1.01–1.11), as was depression diagnosed prior to cancer (AOR: 1.84; 95% CI: 1.00–3.40).

**Conclusion**
Reasons for deviations from guideline recommendations in breast cancer patients differ by age. In decision-making concerning elderly patients, particular attention should be paid to those with pre-existing depressive disorders. Adequately addressing their needs and concerns could prevent inappropriate deviations from guideline recommendations.

Stichworte
Breast cancer; Guidelines; Patient needs; Patient preferences
Erscheinungsjahr
2023
Zeitschriftentitel
Journal of Cancer Research and Clinical Oncology
Band
149
Ausgabe
19
Seite(n)
17297-17306
ISSN
0171-5216
eISSN
1432-1335
Page URI
https://pub.uni-bielefeld.de/record/2989307

Zitieren

Heidenreich A, Fuchshofen R, Elsner S, Gieseler F, Katalinic A, Hübner J. Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. Journal of Cancer Research and Clinical Oncology. 2023;149(19):17297-17306.
Heidenreich, A., Fuchshofen, R., Elsner, S., Gieseler, F., Katalinic, A., & Hübner, J. (2023). Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. Journal of Cancer Research and Clinical Oncology, 149(19), 17297-17306. https://doi.org/10.1007/s00432-023-05446-y
Heidenreich, Andreas, Fuchshofen, Rabea, Elsner, Susanne, Gieseler, Frank, Katalinic, Alexander, and Hübner, Joachim. 2023. “Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany”. Journal of Cancer Research and Clinical Oncology 149 (19): 17297-17306.
Heidenreich, A., Fuchshofen, R., Elsner, S., Gieseler, F., Katalinic, A., and Hübner, J. (2023). Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. Journal of Cancer Research and Clinical Oncology 149, 17297-17306.
Heidenreich, A., et al., 2023. Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. Journal of Cancer Research and Clinical Oncology, 149(19), p 17297-17306.
A. Heidenreich, et al., “Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany”, Journal of Cancer Research and Clinical Oncology, vol. 149, 2023, pp. 17297-17306.
Heidenreich, A., Fuchshofen, R., Elsner, S., Gieseler, F., Katalinic, A., Hübner, J.: Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. Journal of Cancer Research and Clinical Oncology. 149, 17297-17306 (2023).
Heidenreich, Andreas, Fuchshofen, Rabea, Elsner, Susanne, Gieseler, Frank, Katalinic, Alexander, and Hübner, Joachim. “Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany”. Journal of Cancer Research and Clinical Oncology 149.19 (2023): 17297-17306.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2024-05-13T05:43:27Z
MD5 Prüfsumme
684a2cd3b441f1acf18be344a18cf919


Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Suchen in

Google Scholar